Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 572

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats

Yamasaki, Yasundo, Matsuura, Naosuke, Shozuhara, Hidetaka, Onodera, Hiroshi, Itoyama, Yasuto, Kogure, Kyuya·1995·Stroke

Abstract

Background and Purpose It has been suggested that interleukin-1 (IL-1) is a potent inflammatory mediator and that it is synthesized and secreted into the brain parenchyma. The aim of the present study is to evaluate the contribution of IL-1 to brain edema formation after focal brain ischemia. Methods The brain water content was measured to evaluate postischemic brain injury in rats after 60 minutes of middle cerebral artery occlusion and reperfusion. The effects of exogenous application of recombinant human interleukin-1β (rhIL-1β), anti–interleukin-1β neutralizing antibodies (anti–IL-1β), and the IL-1 blocker zinc protoporphyrin (ZnPP) on brain water content were observed, and histological technique was used to measure the infarction size and number of inflammatory cells infiltrated into the brain. Results Transient ischemia induced marked increase of brain water content, necrosis, and neutrophilic infiltration in the cortex perfused by the middle cerebral artery and the dorsal and ventral areas of the caudate putamen. Injection of rhIL-1β into the left lateral ventricle immediately after reperfusion markedly enhanced ischemic brain edema formation in these three areas in a dose-dependent manner (88.4±0.7% and 86.6±0.4% in the dorsal and ventral parts of the caudate putamen, respectively, in rats treated with 10 ng rhIL-1β; P <.01). rhIL-1β also increased the size of the brain infarction, and it tended to increase the number of infiltrating neutrophils in ischemic areas and the number of neutrophils adherent to the endothelium. In contrast, administration of anti–IL-1β and ZnPP into the left cerebral ventricle attenuated the postischemic increase of brain water content and decreased the size of brain infarction (83.5±2.0% and 79.9±2.0% in the dorsal and ventral parts of the caudate putamen, respectively, in rats treated with 10 μg anti–IL-1β; P <.01). The number of neutrophils that infiltrated into ischemic areas also tended to decrease with anti–IL-1β or ZnPP treatment. Conclusions Application of rhIL-1β augmented the increase of brain water content, and application of anti–IL-1β depressed the increase of water content. These results tended to correlate with the neutrophilic infiltration into the parenchyma. It thus appears that IL-1β may play an important role in ischemic brain damage after reperfusion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.str.26.4.676

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 572

Metadata

Authors
Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y., & Kogure, K.
Venue
Stroke
Published
1995-04
Volume
26
Issue
4
Pages
676-681
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2011349107
Cited by
572
References
18
FWCI
16.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats. https://app.cochat.ai/papers/10.1161/01.str.26.4.676
The paper
Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y., & Kogure, K. (1995). Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats. Stroke. https://doi.org/10.1161/01.str.26.4.676

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.